Bechini Angela, Taddei Cristina, Barchielli Alessandro, Levi Miriam, Tiscione Emilia, Santini Maria Grazia, Niccolini Fabrizio, Mechi Maria Teresa, Panatto Donatella, Amicizia Daniela, Azzari Chiara, Bonanni Paolo, Boccalini Sara
a Department of Health Sciences, University of Florence; Florence, Italy.
Hum Vaccin Immunother. 2015;11(1):156-65. doi: 10.4161/hv.34418. Epub 2014 Nov 1.
Invasive pneumococcal diseases (IPD) and community acquired pneumonia (CAP) represent two of the major causes of out-patient visits, hospital admissions and deaths in the elderly. In Tuscany (Italy), in the Local Health Unit of Florence, a project aimed at implementing an active surveillance of pneumococcal diseases in the hospitalized elderly population started in 2013. The aim of this study is to show the results of the retrospective analysis (2010-2012) on hospital discharge records (HDRs) related to diseases potentially due to S. pneumoniae, using a selection of ICD9-CM codes. All ordinary hospitalizations (primary and secondary diagnoses) of the elderly population were included (11 245 HDRs). Among a population of about 200 000 inhabitants ≥65 y, the hospitalization rate (HR) increased with increasing age and was higher in males in all age groups. Almost all hospitalizations (95%) were due to CAP, only 5% were invasive diseases. Only few cases of CAP were specified as related to S. pneumoniae, the percentage was higher in case of meningitis (100%) or septicemia (22%). In-hospital deaths over the three-year period were 1703 (case fatality rate: 15%). The risk of dying, being hospitalized for a disease potentially attributable to pneumococcus (as primary diagnosis) increased significantly with age (P < 0.001), the odds ratio (OR) per increasing age year was 1.06 (95% CI 1.05-1.07) and was higher in patients with co-existing medical conditions with respect to patients without comorbidities. Currently, an active surveillance system on S. pneumoniae diseases with the inclusion of bio-molecular tests (RT-PCR), is a key step to assess the effectiveness of the PCV13 vaccine (13-valent pneumococcal conjugate vaccine) in the elderly population after implementation of vaccination policies. The results of this study will provide the comparator baseline data for the evaluation of a possible immunization programme involving one or more cohorts of the elderly in Tuscany.
侵袭性肺炎球菌疾病(IPD)和社区获得性肺炎(CAP)是导致老年人门诊就诊、住院和死亡的两大主要原因。在意大利托斯卡纳大区的佛罗伦萨地方卫生单位,一项针对住院老年人群实施肺炎球菌疾病主动监测的项目于2013年启动。本研究的目的是利用选定的ICD9-CM编码,展示对2010年至2012年期间与肺炎链球菌潜在相关疾病的医院出院记录(HDR)进行回顾性分析的结果。纳入了老年人群的所有普通住院病例(主要和次要诊断)(11245份HDR)。在约20万≥65岁居民中,住院率(HR)随年龄增长而增加,且在所有年龄组中男性的住院率更高。几乎所有住院病例(95%)是由CAP引起的,只有5%是侵袭性疾病。只有少数CAP病例被明确与肺炎链球菌相关,脑膜炎(100%)或败血症(22%)病例中的这一比例更高。三年期间的院内死亡病例为1703例(病死率:15%)。因可能归因于肺炎球菌的疾病(作为主要诊断)住院死亡的风险随年龄显著增加(P<0.001),每增加一岁的优势比(OR)为1.06(95%CI 1.05-1.07),且有合并症的患者高于无合并症的患者。目前,在实施疫苗接种政策后,纳入生物分子检测(RT-PCR)的肺炎链球菌疾病主动监测系统是评估13价肺炎球菌结合疫苗(PCV13)在老年人群中有效性的关键步骤。本研究结果将为评估托斯卡纳大区一个或多个老年人群队列可能的免疫规划提供比较基线数据。